In one paragraphArticle in Proceedings of the National Academy of Sciences of the United States of America, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
0numbers the graph read from it
0cells of the map it votes in
0citing papers in PubMed
–field-weighted citation impact
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
2 · The registryThe trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
3 · Its place in the literatureWho cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
4 · The recordCorrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
5 · Who and what moneyAuthors and funding
19 authors.
Eleni TsakiriDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
Carlos Campos-MarquesLife and Health Sciences Research Institute (ICVS), University of Minho, Braga 4710-057, Portugal.ORCID 0000-0002-0612-4333 Christina PloumiDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.ORCID 0000-0002-2389-5471 Kalliopi SkourtiLaboratory of Brain exosomes and Pathology - ExoBrain, Institute of Biosciences and Applications, National Centre for Scientific Research Demokritos, Agia Paraskevi 15341, Greece.
Antonis RoussosDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.ORCID 0009-0006-1101-7301 Eirini MytilinaiouDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.
Anastasia Vamvaka IakovouLaboratory of Brain exosomes and Pathology - ExoBrain, Institute of Biosciences and Applications, National Centre for Scientific Research Demokritos, Agia Paraskevi 15341, Greece.ORCID 0000-0003-2031-9337 Ildete Luísa FerreiraCenter for Neuroscience and Cell Biology, University of Coimbra, Coimbra 3004-504, Portugal.ORCID 0000-0001-6552-4479 Chrysoula DioliLife and Health Sciences Research Institute (ICVS), University of Minho, Braga 4710-057, Portugal.
Despoina D GianniouDepartment of Biology, National and Kapodistrian University of Athens, Athens 15784, Greece.ORCID 0000-0002-8111-6528 Martina SamiotakiBiomedical Sciences Research Center "Alexander Fleming", Institute for Bio-innovation, Vari 16672, Greece.ORCID 0000-0001-9952-0636 Jonas CamposLife and Health Sciences Research Institute (ICVS), University of Minho, Braga 4710-057, Portugal.
Clarissa WaitesDepartment of Pathology and Cell Biology, Taub Institute for Research on Alzheimer's Disease and Aging Brain, Columbia University Irving Medical Center, New York, NY 10032.
Ioannis P TrougakosDepartment of Biology, National and Kapodistrian University of Athens, Athens 15784, Greece.ORCID 0000-0002-6179-2772 Joana M SilvaLife and Health Sciences Research Institute (ICVS), University of Minho, Braga 4710-057, Portugal.ORCID 0000-0002-8257-3413 A Cristina RegoCenter for Neuroscience and Cell Biology, University of Coimbra, Coimbra 3004-504, Portugal.ORCID 0000-0003-0700-3776 Ioannis SotiropoulosLife and Health Sciences Research Institute (ICVS), University of Minho, Braga 4710-057, Portugal.
Konstantinos PalikarasDepartment of Physiology, Medical School, National and Kapodistrian University of Athens, Athens 11527, Greece.ORCID 0000-0001-6992-5560 Funding
COMPETE 2020 - Operational Programme for Competitiveness and Internationalisation and Portuguese national funds via FCT - Fundação para a Ciência e a Tecnologia, UIDB/04539/2020EC | Horizon Europe | Excellent Science | HORIZON EUROPE European Research Council (ERC) 101077374Fondation Sante 19656Hellenic Foundation for Research and Innovation (H.F.R.I.) 15493National Recovery and Resilience plan Greece 2.0, funded by the European Union - NextGenerationEU TAEDR-0535850NIH grant 4R01AG069941-02the Greece 2.0, National Recovery and Resilience Plan Flagship program TAEDR-0535850The Greek Research Infrastructure for Personalized Medicine (pMED-GR) MIS 5002802
6 · The paper itselfAbstract
Mitochondrial damage is a shared hallmark of brain aging and neurodegeneration. While pathological Tau mutations disrupt mitochondrial dynamics and function, the physiological role of wild-type (WT) Tau in the maintenance of mitochondrial homeostasis remains poorly understood. Here, using
Indexed as
Caenorhabditis elegans ProteinsMitochondriaMitochondrial Dynamicstau ProteinsAnimalsCaenorhabditis elegansGTP PhosphohydrolasesHomeostasisMiceMice, KnockoutCaenorhabditis elegans ProteinsFZO-1 protein, C elegansGTP Phosphohydrolasestau Proteinsmitochondriamitochondrial dynamicsneurodegenerationneuronTau
Identifiers
PMID42378301
PMCPMC13342828
What OpenQuestion holds
Textmetadata
LicenceCC BY
Read underepoch 390